Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.330
-0.220 (-8.63%)
Mar 3, 2026, 4:00 PM EST - Market closed
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $5.34 million as of March 4, 2026. Its market cap has decreased by -13.90% in one year.
Market Cap
5.34M
Enterprise Value
1.22M
1-Year Change
-13.90%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $5.34M, a decrease of -88.81%. That is a compound annual growth rate of -20.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 5.30M | 6.00% |
| Dec 31, 2025 | 5.00M | -19.35% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 6.02M |
| Aprea Therapeutics | 5.84M |
| Revelation Biosciences | 5.79M |
| Calidi Biotherapeutics | 5.40M |
| Processa Pharmaceuticals | 5.30M |
| Silexion Therapeutics | 5.28M |
| Cyclerion Therapeutics | 5.18M |
| VivoSim Labs | 5.11M |